Real-World Effectiveness and Safety of Ofatumumab in Relapsing Multiple Sclerosis: Comparison of Treatment-Naïve Patients and Switchers in a Multicenter Cohort - Quiz - MDSpire

Real-World Effectiveness and Safety of Ofatumumab in Relapsing Multiple Sclerosis: Comparison of Treatment-Naïve Patients and Switchers in a Multicenter Cohort

  • By

  • Vincenzo Mangialardi

  • Giuseppe Macchitella

  • Rita Vitobello

  • Antonella Teofilo

  • Nicola Cavalli

  • Caterina Lapucci

  • Marco Vercellino

  • Elisa Idini

  • Jessica Frau

  • Pietro Iaffaldano

  • Paola Cavalla

  • Matilde M. Inglese

  • Eleonora Cocco

  • Damiano Paolicelli

  • May 31, 2026

  • 0 min

Share

Original Source(s)

Real-World Effectiveness and Safety of Ofatumumab in Relapsing Multiple Sclerosis: Comparison of Treatment-Naïve Patients and Switchers in a Multicenter Cohort

  • by Vincenzo Mangialardi, Giuseppe Macchitella, Rita Vitobello, Antonella Teofilo, Nicola Cavalli, Caterina Lapucci, Marco Vercellino, Elisa Idini, Jessica Frau, Pietro Iaffaldano, Paola Cavalla, Matilde M. Inglese, Eleonora Cocco, Damiano Paolicelli

  • May 31, 2026

Related Content

Donor-specific pathological features associate with genetic background, lesion type distribution, and clinical heterogeneity in multiple sclerosis

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

Stem cell-derived extracellular vesicles as immunomodulatory agents: targeting pathological crosstalk in systemic lupus erythematosus and multiple sclerosis